Blue Cross Blue Shield of Massachusetts Urges Everyone to Get the Flu Vaccine
Physicians at Blue Cross Blue Shield of Massachusetts (Blue Cross) encourage everyone to protect themselves, their family and friends from the flu this season by getting vaccinated.
December 20, 2021
by prnewswire
mRNA-1010 quadrivalent flu vaccine shows promise in Phase I study
Moderna’s quadrivalent flu vaccine mRNA-1010 boosted titres against all four strains 29 days after vaccination in young and older adults.
December 15, 2021
by EuropeanPharmaceuticalReview
Flu Vaccine May Protect Against Adverse Events After SARS-CoV-2
Influenza vaccination has a potential protective effect against adverse events within 120 days of a positive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) diagnosis, according to a study published online Aug. 3 in PLOS ONE.
August 18, 2021
‘Most comprehensive’ flu vaccination programme in UK history launching for winter 2021
The government has announced that it will launch the ‘most comprehensive’ flu vaccination programme in UK history for winter 2021.
July 19, 2021
by pharmatimes
Sanofi and Translate Bio start clinical trial for mRNA flu vaccine
The trial will evaluate the safety and immunogenicity of a monovalent flu vaccine candidate coding for the hemagglutinin protein of the A/H3N2 strain of the influenza virus.
June 23, 2021
by expresspharma
Study demonstrates safety and efficacy of co-administering COVID-19 and flu vaccines
A study conducted by Novavax has found that co-administering a COVID-19 vaccine with a flu vaccine is safe and effective, with the efficacy of both jabs appearing to be preserved.
June 18, 2021
by pharmatimes
First-in-human universal flu vaccine trial begins
The US National Institutes of Health have begun a first-in-human trial to assess the safety and immunogenicity of a potential universal influenza vaccine candidate, FluMos-v1.
June 3, 2021
by europeanpharmaceuticalreview
BiondVax Universal Influenza Vaccine Candidate Trial Does Not Meet Primary, Secondary Endpoints
BiondVax Pharmaceuticals announced topline data from the Company's pivotal, phase 3 clinical trial of M-001 as a standalone universal flu vaccine candidate.
October 29, 2020
by americanpharmaceuticalreview
AstraZeneca ships first doses of flu vaccine
AstraZeneca has announced the first shipment of Flumist Quadrivalent vaccine doses have been sent to the US for the upcoming influenza season.
August 17, 2020
by pharmatimes
Researchers develop universal flu vaccine that protects against 6 influenza viruses in mice
A novel nanoparticle vaccine that combines two major influenza proteins is effective in providing broad, long-lasting protection against influenza virus in mice, showing promise as a universal flu vaccine ...
January 9, 2020
by worldpharmanews
Vaccitech Universal Flu Vaccine Passes Phase 2b Clinical Development Milestones
Vaccitech has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the first participants in a Flu 010 study – a Phase 2b, randomized, double-blind, placebo controlled, influenza challenge study being conducted in Antwerp, Belgiu
June 6, 2019
by americanpharmaceuticalreview
Sanofi plans to ‘airlift’ flu vaccine into UK in no-deal event
In the wake of Brexit and the event of a no-deal exit from the European Union, French pharmaceutical giant Sanofi has said it could potentially airlift its flu vaccine into the UK.
March 27, 2019
by pharmatimes